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INTRODUCTION
               Pityriasis rosea is an acute self-limiting disease, probably infective in origin, 
affecting  mainly  children  and  young  adults,  and  characterized  by  distinctive  skin 
eruption  and  minimal  constitutional  symptoms.1 The  initial  lesion,  Herald  patch,  is 
followed several days to weeks later by the appearance of numerous similar-appearing 
smaller lesions, located along the lines of cleavage of the trunk (Christmas tree pattern). 
2
      
SYNONYMS 3
Erythema annulatum (Rayer),
Herpes tonsurans maculosus et squamosus (Hebra),
Lichen annulatus serpiginosus (Wilson),
Pityriasis circine (Horand),
Pityriasis dissemine (Hardy),
Pityriasis marginee et circinee (Vidal),
Pityriasis rubra  aigu dissemine (Bazin),  
Pseudoexantheme erythemato desquamatif (Besnier),
Roseola annulata (Willan),
Roseola furfuracea herpetiformis (Behrend),
Roseola squamosa (Nicolas and Chapard). 3
         Pityriasis Rosea has been reported in all races, the average annual incidence at one 
center was reported to be 0.16 percent.2 In temperate regions, it is more frequent during 
the winter months, whereas in tropical areas, there is some seasonal variation.1  Usually it 
is more common between 10 and 35 years of age, with equal sex distribution or a slight 
female preponderance2. It has been reported to occur among persons in the same 
intimate environment with a higher incidence among dermatologists.4, 32
        Experiments by various researchers to determine the cause of the disease have been 
unsuccessful. Various etiological factors that have been attributed are fungus, bacteria, 
spirochetes, drugs, contact with new garments, psychogenic factors and neurogenic 
factors.
        Currently a virus is believed to play an etiological role.  The prodromal illness, 
generalised exanthema accompanied by constitutional reactions, spontaneous resolution 
and life long immunity, all points towards a viral cause. Extensive research has been 
carried out in patients with Pityriasis rosea with respect to the newly identified human 
herpes virus 6 and 7. It is thus possible and remains an unproved fact that human herpes 
virus 6 and 7 may play a role extensively in some patients with Pityriasis rosea. 4
         In its classical form, Pityriasis rosea is a distinctive dermatoses which is readily 
diagnosed clinically. The initial lesion is a Herald patch or primary plaque, followed by 
a generalised secondary rash after one or two weeks with a typical distribution parallel 
to the cleavage lines of the skin, resembling a “Christmas tree”.1, 2, 4
            The other clinical presentations   are macular, papular, vesicular, lichenoid, 
pustular, purpuric, urticarial and erythema  multiforme like. 3, 4,  The lesions can occur 
rarely over the scalp, palms and soles. After a period of   about six to eight weeks the 
lesions resolve spontaneously leaving a residual hypo or hyper pigmentation without any 
complications. 5
REVIEW OF LITERATURE
DEFINITION
           Pityriasis Rosea of Gibert is defined as an acute, self-limiting disease, probably 
infective in origin, affecting mainly children and young adults, and characterised by a 
distinctive  skin  eruption  and  minimal  constitutional  symptoms.4 or  a  self-limiting 
disorder characterised by the development of asymptomatic erythematous scaly macules 
on the trunk. Pityriasis means fine scales; rosea denotes rose coloured or pink. 2
          Pityriasis Rosea is a clinical diagnosis. The typical form is relatively well defined 
and easily recognised. But, variants or atypical forms including atypical morphology and 
atypical distribution are fairly common, and even a trained eye may find it difficult to 
differentiate these atypical forms of Pityriasis rosea. 5
HISTORICAL BACKGROUND
         The term pityriasis was first coined by the great Greek physician Claudius Galen 
(AD129  -  216)  to  describe  dandruff.  6 Robert  Willan  (1757-1812),  an  Edinburgh 
graduate, was regarded by many as the father of modern dermatology. He devised the 
first modern classification of skin diseases.
         Willan described a rash which he termed as  roseola annulata  in 1798. Pierre 
François Olive Rayer (1793-1867), a French dermatologist, described a very similar rash 
and termed it as  erythema annulatum in 18286. Erasmus Wilson (1809-1884), the first 
professor  of  dermatology  at  London  University,  wrote  about  lichen  annulatus  
serpinginosus  in  1857.  He  described  the  lesion  as  small,  flat,  erythematous  discs,  
bounded by a sharp and distinct margin… and converted into rings.7  These rashes were 
named as pityriasis rosea later. 7
          The term pityriasis rosea was   introduced   by     Camille    Melchoir 
Gibert. 6,  8,  9  He was given the credit  for the first  accurate description of the rash of 
Pityriasis  rosea.  Also,  he  was  the  first  to  report  that  Pityriasis  rosea  is  subject  to 
recurrences and that Pityriasis rosea was not caused by fungus .6
          Pierre-Antoine-Ernest Bazin (1807-1878) in 1862 described the annular type of 
Pityriasis rosea   and he was the first to report prodromal malaise in Pityriasis rosea. 6, 10
           Jean Baptiste Emile Vidal, a French dermatologist, described a similar condition 
which he termed as  pityriasis circiné et marginé. He thought that Pityriasis rosea and 
pityriasis circiné et marginé were different conditions as the latter runs a longer course. 6
            Some dermatologists consider  pityriasis circinata et marginata of Vidal  as a 
special  form of Pityriasis  rosea,  with fewer  and larger lesions often localised at  the 
axillae or groins.  10,  11 Other dermatologists are of the opinion that  pityriasis circinata  
and  pityriasis circinata et marginata  should be synonyms of Pityriasis rosea.  6 Other 
synonyms of Pityriasis rosea are of historical interest only, and include herpes tonsurans 
maculosus,  pityriasis disséminé,  pityriasis rubra aigu,  roseole squameuse of Chapard 
and pityriasis maculate et circinata of Bazin.
Herald patch and centripetal  scaling
         Louis-Anne-Jean Brocq (1856-1928) was the first to describe plaque primitive or 
primitive patch as a distinctive diagnostic sign of Pityriasis rosea in 1887, 27 years after 
Gibert’s description of Pityriasis rosea.7
          In 1899, Alfred Blaschko (1858-1922), a German dermatologist, famous for his 
description of Blaschko’s lines,12 pointed out that in Pityriasis rosea there is exfoliation  
from the centre to the periphery, while in psoriasis desquamation takes place from the  
periphery to the centre. 7
Modern nomenclature and classification
         In  the  International  Classification  of  Diseases,  ninth  Revision,  clinical 
modification (ICD-9-CM), Pityriasis rosea was coded under 696, Psoriasis and similar  
disorders as  696.3.  Pityriasis  circinata  (et  maculata)  was  listed  as  a  synonym  of 
Pityriasis rosea under code 696.3.13
          In ICD-10, pityriasis rosea is coded   under chapter XII - Diseases of the skin and 
subcutaneous tissue as a separate entity L42.14 
. 
EPIDEMIOLOGY
             Pityriasis rosea is seen worldwide. All races are equally susceptible to Pityriasis  
rosea.11 The clinical presentation of Pityriasis rosea is also similar in all races. African 
patients tend to have more extensive rash and involvements of the face and scalp have 
been  reported  to  be  more  frequent  than  Caucasians.  11,  15 It  was  reported  that  an 
erythematous or rosea picture is seldom seen in black patients.16 Asian patients tend to 
have similar rash morphology and extent of involvement as Caucasian patients.11
Incidence and prevalence
           The average annual incidence at one centre was reported to be 0.16 percent 
(158.9 cases per 100,000 person-years) 2. Traore A  et al  in his cross sectional  study 
calculated the prevalence of Pityriasis rosea to be 0.6%. 17 
            There is a slightly increased prevalence in patients with decreased immunity 
such as bone marrow transplant recipients. 18
Age and sex distribution
           Pityriasis rosea affects all ages from infants to the elderly.19 It is uncommon in 
young children(less than 2 years) and elderly (more than 65 years). 2, 4 Most patients are 
between the years of 10 and 35. 2, 4, 5 The youngest reported patient was three months old 
and the oldest reported patient was 83 years old. 5, 20
          Camille Melchoir Gibert stated that females are affected more often than males 21. 
Many studies have reported a slight female preponderance, the most frequently reported 
male: female ratio being 1: 1.2 to 1: 1.5.2,  3,  4,  9,15,11,16,  17,  79  The reason for the apparent 
female predominance is unknown. 
Seasonal Variation
         The data on seasonal variation in Pityriasis rosea have been conflicting.22 In 
temperate  zone,  Pityriasis  rosea is  more common during winter,  whereas  in  tropical 
regions it has been found to be more common during hot and dry seasons. 1, 9, 22 
Case clustering
          Significant temporal clustering independent of seasonal variation occurred in a 
series of patients with Pityriasis rosea. This may be indicative of an infectious cause. 23
AETIOLOGY
          The evidence to support an infectious aetiology for Pityriasis rosea is its distinct  
clinical course. There is a primary skin lesion followed by a secondary eruption, with 
complete  remission  mostly  within  about  eight  weeks.  This course  of  the  disease  is 
similar to most of the viral infections. Moreover, many patients do not have a second 
attack, due to life long immunity a phenomenon which is commonly seen in many viral  
diseases. 2, 24, 25
         Most experiments at transmitting Pityriasis rosea to human beings have failed. But,  
Wile UJ in his study has shown that Pityriasis rosea can be transferred using blister fluid 
or extract of scales of Pityriasis rosea patients. He also showed that bacterial cultures 
from the scales were negative. 26
 
        An electron microscopic study on lesional biopsy of the herald patch reported virus-
like spherical particles with size of 70nm in the intercellular spaces and the cytoplasm of 
Langerhans cells 27. Virus-like particles in the dyskeratotic keratinocytes were also 
reported in another study. 28  The viral
DNA is reported to be present in peripheral blood mononuclear cells and lesional and 
unaffected skin of the majority (80–100%) of individuals with acute pityriasis rosea.1, 4
1. Evidences supporting an infectious aetiology 
a) Case clustering
        Cluster analysis is an epidemiologic approach to investigate a possible infectious 
cause. Significant temporal clustering independent of seasonal variation occurred in a 
series of patients with Pityriasis rosea. This may be indicative of an infectious etiology. 
23, 29
b) Concurrent cases
          There is no report of any true epidemic for Pityriasis rosea. 4 However, since the 
first descriptions of this condition, there have been many case reports of two or more 
patients with Pityriasis rosea in the same family or intimate environment. 30
c) Associations
          Epidemiological studies reported associations of Pityriasis rosea with prodromal  
illness of respiratory tract infections,31 unfavourable social and economic backgrounds, 
17 and contact with patients with Pityriasis rosea. 32
       An interesting study compared the incidence of Pityriasis rosea of dermatologists 
and otolaryngologists. It showed higher incidence of Pityriasis rosea in dermatologists 
when compared to otolaryngologists, claiming that frequent exposure to Pityriasis rosea 
by dermatologist during their practice led to an increased risk. 4, 32
d) Immunology
        Immunohistologic data shows perivascular aggregates of predominantly active CD4 
T lymphocytes in the superficial dermis. An increase in Langerhan cells, which is an 
antigen  presenting  cell  and  the  expression  of  HLA-DR+ antigen  on  the  surface  of 
keratinocytes located around the area of lymphocytic exocytosis suggesting an infectious 
aetiology for Pityriasis rosea. 33, 34, 36
e) Human Herpes virus 6 and human Herpes virus 7
         Herpes virus like particles has been found in 71% of Pityriasis rosea lesions. 
Human herpes virus 6 and Human herpes virus 7 have been suggested as the cause for 
the eruption. The viral DNA is reported to be present in peripheral blood mononuclear 
cells in the lesional and unaffected skin of majority (80-100%) of individuals with acute 
Pityriasis rosea. Human herpes virus 7 is detected slightly more frequently than human 
herpes virus 6. However, evidence for the presence and activity of human herpes virus 6 
or human herpes virus 7 is also found in a proportion (10–44%) of unaffected 
individuals. Hence, its role as a causative agent is yet to be proved.4, 35, 48, 94 
f) Influenza and Para influenza viruses
         One study analysed whether Pityriasis rosea is due to Influenza and Parainfluenza  
viruses as many patients gave a history of antecedent upper respiratory illness, but the 
investigators  concluded  that  Pityriasis  rosea  is  not  related  to  these  viral  infections 
because there was no significant rise of antibody for these viruses. 37
g) Picornovirus
        Earlier work has demonstrated Picornovirus like intra nuclear inclusion bodies in 
the tissues of African green monkey, inoculated with fluid from Pityriasis rosea lesions; 
however other attempts failed to demonstrate this virus genome. 38
i) Enterovirus
        Enteroviruses tend to produce a variety of exanthemas. A case has been reported 
with Pityriasis rosea like skin eruption with a typical  Christmas tree pattern and the 
demonstration of a monoclonal antibody that identified enteroviruses. This suggests that 
an unusual enterovirus could be the possible cause of the rash. 39 
k) Streptococcus
        A recent Indian study concluded that there is no association between streptococcal 
pharyngitis and pityriasis rosea.41                                              
2. Autoimmunity
      An autoimmune element in the pathogenesis of Pityriasis rosea has been suspected 
by some investigators.42 They proposed that Pityriasis rosea is an auto aggressive disease 
affecting a small, genetically susceptible subset of the population. They believed that an 
infectious agent may be the trigger factor in the pathogenesis.
        It  has  been  reported  that  28%  of  patients  with  Pityriasis  rosea  have  T 
lymphocytotoxic antibody, an autoantibody present in 82% of patients with systemic 
lupus erythematosus (SLE).42 Pityriasis rosea has also been reported to occur in a patient 
with Behçet’s disease.  Whether the Pityriasis rosea eruption is related to the disease 
process, the interferon treatment or is totally coincidental is unknown.43 
         Treatment with systemic corticosteroids for recalcitrant Pityriasis rosea has been 
advocated.24 In a study 20 cases with extensive inflamed eczematised Pityriasis rosea 
were treated with systemic steroids with a short tailing course of oral prednisolone over 
two to three weeks. Improvement was noted in all 20 patients which may support the 
hypothesis that Pityriasis rosea may be an autoimmune disease, but it was not known 
that, whether such improvement was related to the systemic corticosteroids per se or due 
to spontaneous remission.44 
         Treatment  of  Pityriasis  rosea with erythromycin has been reported to  have 
remarkable effects in modifying the course of the disease.45 Apart from its effects as an 
antibiotic, erythromycin also has anti-inflammatory and immunomodulatary effects. In 
the case of autoimmunity or immune dysfunction being an important component in the 
pathogenesis of Pityriasis rosea, these effects may also contribute towards the action of 
erythromycin in Pityriasis rosea.46
3. Atopy and genetic predisposition
         In a case control study, patients with Pityriasis rosea and their relatives were 
reported  to  have  a  higher  incidence  of  asthma  and  eczema.   Such findings  support 
genetic  predisposition  being  an  underlying  factor  in  Pityriasis  rosea,  and  that  an 
infectious agent may be the trigger factor.3, 4, 42. 
4. Other factors
a) Psychogenic aetiology:  has also been proposed in highly stressed individuals. 
Though  the  psycho  somatic  theory  is  considered  to  be  unlikely,  it  may  the 
depressant  effect of stress on the immune system that makes these individuals 
more susceptible to Pityriasis rosea.47
b) New Clothing:  Because,  the distribution of  the skin lesion in  Pityriasis  rosea 
sometimes coincides with the location of various garments of the body, it has been 
thought that these may precipitate or affect the course of the disease.3
c) Pregnancy:  The  slightly  increased  prevalence  of  Pityriasis  rosea  in  pregnant 
women is possibly due to new clothing, but this fact has not been confirmed.3
d) Bone Marrow transplantation, Administration of BCG/ Hep B/ Pneumovac, 
Insect Bite, Wasp sting have all been implicated in the causation of the disease, 
but none has been proved. 1, 18, 48  
e) Drugs: Many drugs have been attributed in causing Pityriasis like rashes for 
example arsenic. 4                                                                           
Probable Pathogenesis:
             Human herpes virus 7 and human herpes virus 6 do not infect keratinocytes but 
instead infect CD4+ T cells within blood and are retained within these cells in a latent 
form in most individuals. These cells are the likely source of cell-free viral DNA found 
in plasma or serum samples of patients with Pityriasis rosea. They are also the likely 
source  of  the  scattered  perivascular  and  perifollicular  virus-positive  cells  observed 
within some lesions of Pityriasis rosea.49
CLINICAL FEATURES AND DIAGNOSIS
Classical pityriasis rosea
           The characteristic features of a Classical pityriasis rosea are as follows:
Herald  Patch  (Synonyms:  Mother  patch,  Primary  Plaque  or  Plaque  Primitive, 
Primary Medallion)                             
          The herald patch is the first lesion to appear in a Pityriasis rosea patient. It is a 
solitary round or oval lesion with a central wrinkled salmon coloured area and a darker 
red peripheral zone separated by a collarette of fine scaling. It may be hyper pigmented 
in dark individuals.2 It may vary from 1-10 cm in diameter. The herald patch may occur 
anywhere on the body, although the trunk and upper arms are its predilected sites i.e. in 
the areas covered by clothes.24 Rarely it may occur on the face, scalp or the penis4. When 
the plaque is irritated, it may have an eczematous papulovesicular appearance.3
         The Herald patch is seen in 80% of all Pityriasis rosea patients. 47 In another study, 
where a series of 127 patients were examined, 76 % were reported to have a herald 
patch.50 However, its true incidence is difficult to be ascertained as it is easily missed by 
the patients. 
       Herald patch sometimes develops at the site of recent lesion such as minor 
cutaneous infection, flea bite, wasp sting, and BCG or Hepatitis B vaccination1, 7. 
Prodromal symptoms are  absent in most of the patients.4  In a minority of patients, flu-
like symptoms have been reported, including general malaise, headache, nausea, loss of 
appetite, fever, and arthralgias.3
Secondary eruption
      The herald patch is followed by the secondary eruption. The range of the interval 
between primary and secondary eruptions can be as wide as few hours to months, but is 
predominantly around 5 to 15 days.1,  4 Two main types of lesions are seen, one is the 
lesion of similar morphology as the herald patch, but smaller in size, and the other is  
small,  red,  non  scaling  papules  that  gradually  increase  in  number  and  spread 
peripherally. Both the forms can exist concomitantly.2  Old lesions usually fade in two 
weeks but new lesions will continue to appear in crops at 2-3 days interval over a week 
or 10 days.1, 2, 24
Collarette scaling
        The word pityriasis comes from the Greek meaning bran. 51 In Pityriasis rosea, it 
describes the fine desquamation of the lesions. Collarette means collar-like. This term 
denotes the  characteristics of the centripetal scaling pattern in Pityriasis rosea, the 
scaling is circinate or oval and  the morphology of scaling is such that fine fragments of 
scales are attached only at the periphery, reflecting a tendency of peeling from the centre 
towards the edge. 51 The whole lesion can also be covered with a fine scale initially, then 
desquamating to leave collarette scaling around each lesion. The amount of scales 
present is highly variable.51 When stretched across the long axis the scales tend to fold 
across the lines of stretch which is called as the              “Hanging Curtain” sign. 52 
Collarette scaling is important for the diagnosis for Pityriasis rosea. However, its 
recognition is sometimes difficult.
Truncal distribution 
         In classical cases, only the trunk   and proximal aspects of the extremities are 
involved. This distribution pattern is traditionally termed as  T-shirt-and-shorts,  high-
necked short sleeved vest  or bathing suit  pattern.50   However, it has been reported that 
lesions can be distal to the elbow in 4.8% to 12% of cases, and distal to the knees or the  
elbows in 6% to 15.3% of cases. 4, 21 
        The distal involvement is commonly seen in older patients.21 The face is usually 
spared, except in children.2,  4 Palms and soles are spared in most cases.21 This fact is 
usually taken as one of the differentiating features from secondary syphilis. However, 
palmoplantar  involvement  in  Pityriasis  rosea  showing  lesions  similar  to  secondary 
eruptions elsewhere in the body was reported by Klauder JV as early as 1924.10
Symmetry
       The secondary rash in Classic Pityriasis Rosea is very symmetrical.2, 3, 5, 53
Orientation
        On the anterior and posterior aspect of trunk the characteristic orientation of the 
secondary  eruptions  has  been  described  in  various  terms  as  Christmas-tree  pattern, 
inverted Christmas-tree pattern,  fir tree pattern,  parallel to the ribs  or  along the skin  
cleavage lines, that is, on the anterior trunk, the rash seems to be radiating medially and 
inferiorly,  while  on  the  posterior  trunk,  the rash  seems to  be  radiating  laterally  and 
inferiorly.  This  orientation  along the  skin  cleavage line  is  most  characteristic  at  the 
anterior and posterior axillary folds and supraclavicular areas. However the underlying 
mechanism for this orientation pattern is unknown .7, 54
Pruritus
        Pruritus in Pityriasis rosea may vary from no pruritus at all to severe pruritus.  
Pruritus is severe in 25% of patients; slight to moderate in 50% and absent in 25% of 
patients.2 When Pityriasis rosea is irritated, itching is usually prominent. 3, 55 The nature 
of pruritus in Pityriasis rosea has not been specifically reported in the literature. 
Spontaneous remission
       The duration of the rash varies from 2 to 12 weeks, but may last for as 
long as five months which is known as Pityriasis rosea perstans.56 Post-inflammatory 
hyper or hypopigmentation may also last for month.5 Pityriasis rosea has been termed as 
Doctor’s Delight, owing to spontaneous remission with not much of  complications. 50
 Relapse
        Second attacks of pityriasis rosea occur in about 2% of cases after an interval of a 
few months or many years.1 Rarely, partial or complete relapse of a fading eruption may 
be seen4. In a series of 826 patients, the rate of relapse was noted as 2.8%. 47  The 
eruption is usually less severe in relapse. 47
Atypical pityriasis rosea
          Atypical forms of Pityriasis rosea are fairly common. An epidemiological study 
estimated  that  up  to  39% of  patients  with  Pityriasis  rosea  may  have  some  atypical 
features. Atypical features include atypical rash morphology, rash size, rash distribution 
and site of the lesions. 17, 57
Atypical Herald Patch 
            The Herald Patch may be absent or undetected in about 20% of cases.4 There 
may be two or more patches. The primary plaque may be the sole manifestation of the 
disease or only one of two lesions. 3
Atypical morphology of secondary lesions
           Atypical rash morphology includes papular, vesicular, purpuric or haemorrhagic, 
urticarial, lichenoid and erythema multiforme - like forms. 3, 4, 58, 95
           Vesicular Pityriasis rosea usually presents as a generalised eruption of 2-6 mm 
vesicles. Palms and soles can be involved, but like the classic Pityriasis rosea, the face 
and  scalp  are  usually  spared.  Vesicular  Pityriasis  rosea  is  said  to  be  commoner  in 
children and young adults and is more commonly seen in Africa 59, 60. Vesicular Pityriasis 
rosea may exist alone or may be concomitantly seen with classic oval scaly Pityriasis 
rosea patches.58 Vesicular Pityriasis rosea may be severely pruritic and extensive.61 The 
lesions may simulate a wide spread eczematous eruption with weeping and crusting. In a 
series of 138 patients with Pityriasis rosea, four patients were reported to have vesicular 
Pityriasis  rosea.11 It  is  believed  that  the  vesicular  lesions  are  due  to  exaggerated 
spongiosis and exocytosis with intraepidermal separation. 62
       Purpuric Pityriasis rosea usually presents with tiny purpuric spots affecting the trunk 
and proximal part of the extremities. Accompanying petechiae may be visible over the 
palate.  The  histopathology  is  usually  the  same as  for  classic  Pityriasis  rosea.  Some 
lesions  may  reveal  mild  to  moderate  extravasation  of  erythrocytes  in  the  papillary 
dermis,  associated  with  dilatation  of  capillaries.  Histopathological  evidence  of 
accompanying allergic vasculitis  is  usually  absent.  The prognosis is  the same as for 
classic Pityriasis rosea. It is likely that  haemorrhagic and purpuric  Pityriasis rosea are 
different terminologies describing the same condition. 62, 63, 64
        Urticarial Pityriasis rosea, also known as  pityriasis rosea urticata, present with 
considerably  raised  lesions  resembling  urticarial  wheals.  It  is  often  accompanied by 
intense pruritus. 10, 68
Atypical size of lesions
        Pityriasis rosea gigantea of Darier  is rare characterised by large sized plaques 
which can have sizes up to the patient’s own palm. In one patient, the herald patch was 
of  the size and the shape of a pear  over the right scapular region.65,  68 The secondary 
lesions were of sizes about 5cm by 6.3cm  65.  The clinical  course of pityriasis rosea 
gigantea of Darier is similar to classic Pityriasis rosea .10, 68
        Papular Pityriasis rosea is the other extreme in the size of Pityriasis rosea lesions. 66 
It is more often seen in children.68 The primary eruption consists of a coalescence of 
papules which represents the herald patch.  The secondary eruption, numerous small 
papules 1-2 mm in diameter may be seen together with the classical oval Pityriasis rosea 
patches.10
Atypical distribution of lesions
       Cases with relatively asymmetrical rash distribution are uncommon but not rare. 
Atypical distribution of lesions is frequently in the form of acrally distributed rash, also 
known as Pityriasis rosea inversus. 67, 68, 95 The face, axilla and groin are predominantly 
affected. In the limb-girdle type, the eruption is restricted to the shoulders or the hips. 22 
Even cases with strictly unilateral involvement have been reported. 69
        In localised Pityriasis rosea the lesions are confined to one part of the body4. The 
trunk is usually the predilected site. The rash morphology and time course of localised 
Pityriasis rosea are the same as for classic Pityriasis rosea. 70
        Pityriasis circinata et marginata is sometimes considered as a special or atypical 
form of Pityriasis rosea. 10, 11 This is mainly seen in adults, with fewer and larger lesions 
often localised to the axilla or inguinal region. Pityriasis circinata et marginata usually 
persists for a longer period than classical Pityriasis rosea, and sometimes precedes a 
typical generalised Pityriasis rosea rash4. In a series of 138 patients with Pityriasis rosea, 
four patients were reported to have pityriasis circinata et marginata of Vidal. 11 
Atypical site of lesions
       It  has been reported that  involvements of the face,  scalp,  hands and feet  are 
uncommon in Pityriasis rosea.  10 The scalp, eyelids and penis can also be involved in 
Pityriasis rosea.10Two cases of Pityriasis rosea with palmoplantar plaque lesions have 
been reported.71 Atypical lesions on the patients feet and wrist may occur, because of 
their respective environments which are prone to sweating and irritation (lesion under 
the watch band; socks and shoes on the feet).This variant is known as Pityriasis Rosea 
Irritata, which may resemble guttate psoriasis. 51, 68
         The oral cavity is another atypical site for Pityriasis rosea lesions.68, 72 Oral lesions 
may occur in discrete or confluent patches. They may be white, haemorrhagic, erosive, 
or  bullous.  Two  major  types  of  oral  involvement  were  described:  tiny  punctate 
haemorrhages with pinhead erosions over the buccal and palatal mucosa, and discrete, 
slightly  elevated  lesions sometimes with superficial  erosions  can be seen.11 Intraoral 
lesions  are  usually  asymptomatic.  They  either  follow a  similar  course  as  cutaneous 
Pityriasis rosea lesions, or tend to subside several days before the cutaneous eruption. 11, 
68 Rarely, Pityriasis rosea lesions can also occur over vulval region.1
Drug induced pityriasis rosea-like rashes
         Many drugs including arsenic,4  tyrosine kinase inhibitor,73,74  captopril,75 gold,68 
isotretinoin,68 lithium,14 non-steroidal  anti-inflammatory  agents,76 omeprazole77 and 
terbinafine78 have been implicated in causing Pityriasis rosea-like rashes. 
        It was reported that when ampicillin was consumed by 29 patients with Pityriasis 
rosea,  the  lesions  got  worse  and  urticated.79 The  face  was  frequently  involved  and 
pruritus was also more frequent. This phenomenon was analogous to ampicillin rash in 
infectious mononucleosis. It is also reported that this intolerance to ampicillin was not 
seen with other antibiotics such as erythromycin or co-trimoxazole. 79
Characteristics of Drug induced Pityriasis rosea
          Drug induced Pityriasis rosea may be of the classic type, but it often shows 
atypical features. The lesions are generally less numerous, larger and more scaly than 
usual.  The Herald Patch and the Christmas tree distribution are frequently absent.  In 
addition, associated oral lesions, persistence of lesions, striking resistant to therapy, post 
inflammatory hyper pigmentation and transformation to lichenoid dermatitis are more 
common.3
Drugs associated with a Pityriasis rosea like eruption
                           
                     Arsenic                                   Isotretinoin
                     Barbiturate                              Interferon α
                     Bismuth                                  Ketotifen
                     Captopril                                 Lithium
                     Clonidine                                 Levamisole
                     Diptheria Toxoid                     Metronidazole
                     D-Penicillamine                       Methopromazine 
                     Gold                                          Omeprazole
                     HydroxyChloroquine               Terbinafine
                     Imatinib mesylate    
Pityriasis rosea and related physical conditions
        In rare cases enanthema may occur with haemorrhagic macules and patches, bullae  
on the tongue and cheeks or lesions that resemble aphthous ulcers.2
        Pitting of Nails and onychodystrophy after Pityriasis rosea has also been reported.80 
Lymphadenopathy  may  occur  in  patients  in  Pityriasis  rosea,  especially  early  in  the 
course of the disease and in association with flu like symptom.2  Other associated skin 
diseases more commonly found along with Pityriasis rosea are atopy and seborrheic 
dermatitis and acne vulgaris.3
Systemic Involvement 
         Involvement of internal organs has not been documented in Pityriasis rosea. 81
Complications
          No complications have been reported except for flu like symptom  but these are 
relatively mild if they occur. 2
Differential diagnoses 
1. Christmas Tree Eruptions:  The following conditions also have Christmas tree 
distribution of lesion and should be differentiated from Pityriasis rosea.
• Erythema dyschromicum perstans (Ashy Dermatosis): In ashy dermatosis slight 
erythema precedes the characteristic bluish brown patches following the clefts of 
the skin.  The colour also differs  from the pigmentation that  follows Pityriasis 
rosea  and  fades  faster  in  Pityriasis  rosea.  Histopathology  shows  hydropic 
degeneration of the basal cell layer of epidermis which is different from that of 
Pityriasis rosea.3
• Lichen planus and lichenoid reactions: These are often caused by drugs and have 
a Pityriasis rosea distribution. The lesions have the characteristic of both Pityriasis 
rosea and Lichen planus on naked eye examination and also on microscopy.3
• Pityriasis  lichenoides  et  varioliformis  acuta  or  chronica:  These  lesions  also 
follow lines of cleavage of the skin and may present  with a “Christmas Tree” 
pattern on the trunk, but as a rule, typical lesion will be found on the extremities. 
Histologically also, it mimics Pityriasis rosea. 3, 82 
• Kaposi’s sarcoma:  May present with a Pityriasis rosea like distribution pattern 
with oval, violaceous papules and nodules chiefly on the arms, neck and trunk.3
2. Annular eruptions and Herald patch: Annular Pityriasis rosea and Herald patch 
should be differentiated from the following clinical entities.
• Pityriasis Alba: It usually occurs in children and young adults over the face, arm 
and  thorax,  and  when  the  lesions  are  irritated  an  annular  erythema  develops 
similar to Pityriasis rosea.3
• Nummular  eczema:  Nummular  eczema  localised  to  the  trunk  can  also  pose 
difficulties  in  diagnosis,  but  these lesions  are  usually  round,  not  oval  and the 
papulovesicular elements are more prominent than in Pityriasis rosea. also, the 
duration of the disease is more when compared to Pityriasis rosea.
• Seborrheic dermatitis: can present as annular or figurate lesion on the trunk and 
arms,  but  as  a  rule  the  scalp  and face  show the  typical  picture  of  seborrheic 
dermatitis and the course is protracted.3 
• Dermatophyte infection: may mimic Pityriasis rosea in acute stages.  This can be 
ruled out by mycologic investigations like scraping for KOH examination or by 
fungal culture.3
3. For Papular Eruptions: When there is no primary plaque, the papular eruptions 
should be excluded from 
• Drug Eruptions and erythema multiforme3
• Guttate psoriasis: is very difficult to differentiate from Pityriasis rosea when only 
few lesions are present. Histological examination is not always helpful. Psoriasis 
runs a longer course. In psoriasis the lesions are surmounted by silvery scales.4
• Secondary syphilis: involvement of palms and soles is characteristic of secondary 
syphilis, but it is rare in Pityriasis rosea. There is no herald patch and the lesions 
are roseolar or maculopapular.4 Serologic test for syphilis will  differentiate the 
two.3
4. Purpuric  Pityriasis  rosea:  should  be  differentiated  from  vasculitis  and 
haematological diseases. 5 
5.  Inverse Pityriasis rosea: Papular Acrodermatitis of Childhood (Gianotti-Crosti 
Syndrome). 3,  83
6. Other Differential diagnosis: Hodgkins disease, mycosis fungoides, gastric 
carcinoma and bronchogenic carcinoma are associated with Pityriasis rosea like 
eruptions.24
Diagnostic criteria
A set of diagnostic criteria has been devised and validated for Pityriasis rosea, but its 
reliability and applicability in other ethnic groups remains to be ascertained.22
Diagnostic criteria of pityriasis rosea
A patient is diagnosed as having pityriasis rosea if:
1. On at least one occasion or clinical encounter, he / she has all the essential 
clinical   features and at least one of the optional clinical features, and
2. On all occasions or clinical encounters related to the rash, he / she does 
not have any of the exclusional clinical features.
Essential clinical features:
1. Discrete circular or oval lesions
2. Scaling on most lesions
3. Peripheral collarette scaling with central clearance on at least two lesions
Optional clinical features (at least one has to be present):
1.  Truncal  and proximal  limb distribution,  with  less  than 10% of  lesions 
distal to mid-upper-arm and mid-thigh
2. Orientation of most lesions along direction of the ribs
3. A herald patch (not necessarily the largest) appearing at least two days 
before the generalized eruption
Exclusional clinical features:
1. Multiple small vesicles at the centre of two or more lesions
2. Most lesions on palmar or plantar skin surfaces
3. Clinical or serological evidence of secondary syphilis
Investigations
         Pityriasis rosea is a clinical diagnosis. Lesional histopathological changes are non-
specific. Taking a lesional biopsy thus cannot confirm a diagnosis of Pityriasis rosea. 
The roles of investigations are to exclude important differential diagnoses and to provide 
additional support for the diagnosis in atypical cases. Histopathological examination was 
not performed even in a recent clinical trial on Pityriasis rosea, as  it seldom helps in  
diagnosis according to the investigators 45. Skin scraping for potassium hydroxide smear 
and fungal culture may be indicated only if tinea corporis is suspected clinically.3
        It has been suggested that, for adolescents at least, secondary syphilis should be 
excluded with serology tests for  all  cases diagnosed with Pityriasis  rosea,  especially 
when the  palms  or  soles  are  affected,  when  a  herald  patch  is  not  seen,  or  when 
morphologic atypia complicates the clinical picture .84
      The blood picture is usually normal, but leukocytosis, neutrophilia, basophilia and 
lymphocytosis  have been reported.  Slight  increase in erythrocyte sedimentation rate, 
total protein, α1 and α2 globulins and albumin also have been observed. Tests for 
rheumatoid factor,  cold agglutinins and cryoglobulins have been normal but  none of 
these helps in diagnosing Pityriasis rosea. 3, 85
PATHOLOGY
 
Lesional Pathology
         Histopathological changes in Pityriasis rosea are non-specific. Lesional biopsy can 
therefore provide evidence to support the diagnosis and exclude certain important 
differential diagnoses only, but not to confirm a diagnosis of Pityriasis rosea. 
Histopathological changes in the generalised eruption typically shows a reaction pattern 
classified   as superficial perivascular dermatitis. 24, 85   The epidermal findings include 
focal parakeratosis, however in rare cases it may be diffuse. The granular cell layer is 
reduced or absent. Slight acanthosis, focal spongiosis which may progress to 
vesiculation can be seen. A most impressive sign of Pityriasis rosea is the presence of 
microscopic vesicles, sometimes subcorneal in a clinically dry lesion. In the dermis, a 
superficial perivascular infiltrate of lymphocytes, histiocytes and occasionally 
eosinophils may be observed. There is papillary dermal oedema and a variable number 
of extravasated red cells.34 
        Extravasated red cells may be seen not only in the papillae but also in the 
epidermis. The papillary dermal red cells are particularly prominent in purpuric 
Pityriasis rosea. 7, 85
  
         Histopathological changes in the herald patch are similar to generalised eruption. 
The Herald patch may have in addition to the histopathological changes described above 
more pronounced acanthosis, less of spongiosis and deeper and denser perivascular 
inflammatory infiltrate and papillary dermal oedema. 3, 5
        Other  histologic  features  that  have  been  reported  include  focal  necrosis  of 
epidermal  cells;  dyskeratotic  cells  in  the  upper  and  middle  epidermis  with  an 
eosinophilic,  homogenous appearance,  suggesting primary damage to the basal  cells; 
multinucleated epidermal giant cells can be seen as in other inflammatory states.  Focal 
acantholytic dyskeratosis have also been reported.86, 87, 88
      Histological changes in Pityriasis rosea may also closely resemble superficial gyrate 
erythema,  erythema  annulare  centrifugum,  guttate  psoriasis,  and  small  plaque 
parapsoriasis. As small vesicles or micro-abscesses similar to those present in psoriasis 
are sometimes seen, the histological differentiation of Pityriasis rosea from early lesions 
of guttate psoriasis can be particularly difficult.28 The distinction of guttate psoriasis 
from Pityriasis rosea should therefore still be made on clinical ground.51
          An electron microscopy study on lesional biopsy specimens of patients with 
Pityriasis rosea showed cytolytic changes in keratinocytes adjacent to Langerhans cells, 
which  are  the  antigen  presenting  cells  and  these  findings  suggest  a  cell  mediated 
immune reaction in the epidermis. 89
        A study of skin biopsy specimens from patients with Pityriasis rosea reported high 
CD4: CD8 ratio in the dermal T cell infiltrate in active Pityriasis rosea lesions. This ratio 
significantly decreases in old inactive Pityriasis rosea lesions.1, 90 This might indicate that 
Pityriasis  rosea is  also an inflammatory dermatosis  similar  to  psoriasis  and that  cell 
mediated immunity may play an important role in the pathogenesis of the disease. 90
Alterations in the peripheral blood
      In the peripheral blood, elevation of the erythrocyte sedimentary rate, a slight  
decrease  in  the  number  of  T-lymphocytes  and  an  increase  in  B-lymphocytes  were 
reported.47 These changes are similar to those seen during acute viral infections, offering 
some support for a viral aetiology in Pityriasis rosea. 47
        The case controlled study reported normal levels of serum IgG and IgA but higher 
levels of total IgM, decreased C3 and normal C4 in patients with Pityriasis rosea. These 
findings were compatible with a viral aetiology for Pityriasis rosea.91
QUALITY OF LIFE AND Pityriasis rosea
       The QUALITY OF LIFE (QOL) of patients with Pityriasis rosea is significantly less 
affected when compared to patients with atopic dermatitis and acne vulgaris. The effects 
on the QOL of patients with Pityriasis rosea doesn’t correlate with rash severity, but 
rather correlates significantly with the patient’s concerns regarding the aetiology and 
infectivity of the disease.92
TREATMENT 
a) Since Pityriasis rosea is self limited, there is no need for active treatment. 1, 2
b)  For all patients: Education about the disease process and reassurance.2 
c) Water, soap, wool and sweating may cause irritation and should be avoided in 
acute stages.
d) For patients with mild pruritus zinc oxide or calamine lotion will suffice.
e) For patients with pruritus severe enough to disturb the quality of life, along with 
topical preparation like zinc oxide or calamine lotion, a course of Erythromycin 
can be given (Tab. Erythromycin 250 mg QID for 2 weeks; for children 25-40 
mg/kg/day in four divided doses for 2 weeks).45 along with anti histamines and 
mid potency topical corticosteroid for symptomatic relief of pruritus.3
f) The use of  systemic corticosteroids should be restricted to adult  patients  with 
exceptionally  recalcitrant  and  symptomatic  Pityriasis  rosea  resistant  to  other 
treatments.44
g) For  patients  early  in  the  disease  course  who demonstrated  associated  flu  like 
symptoms and/or extensive skin diseases, oral Acyclovir 800mg, 5 times daily for 
1 week or equivalent Acyclovir derivatives may hasten recovery from disease. 2, 76
h) In certain patients phototherapy has been found to be useful. Ultraviolet radiation 
in  erythmogenic  doses  (a  dose  large  enough  to  produce  erythema  and 
desquamation) is necessary. But, post inflammatory pigmentation at the site of the 
Pityriasis  rosea  lesion  following  UV radiation  therapy  has  prompted  warning 
against this form of treatment. 2, 3, 93 
i) Dapsone has been used in severe vesicular Pityriasis rosea.3
AIM OF THE STUDY
TO ANALYSE
                                             
1) The incidence of Pityriasis rosea in Coimbatore Medical College Hospital, 
Coimbatore during the period May 2008 to April 2009. 
2) Age and sex distribution.
3) Probable aetiological factors.
4) Symptoms of Pityriasis rosea.
5) Morphological types and distribution of Pityriasis rosea.
6) Associated cutaneous findings.
7) Course of the disease.
MATERIALS AND METHODS
                      The study was conducted at the Department of Dermatology, Coimbatore 
medical college during the period May 2008 to April 2009. All the patients attending the 
dermatology out patient department at Government general hospital, Coimbatore, were 
screened  and  patients  with  pityriasis  rosea  were  enrolled.  The  clinical  diagnosis  of 
Pityriasis Rosea (Pityriasis rosea) was made in each case based on the morphology and 
distribution of the skin lesions.
Inclusion criteria: 
                    Patients living in and around Coimbatore, who were willing for follow up 
and who had not taken any treatment for the present condition.
Exclusion criteria: 
                    Patients who already tested positive for VDRL, ELSIA for HIV and for 
spores / hyphae in KOH examination of the scales. Patients who were pregnant at the 
time of diagnosis of Pityriasis Rosea.
                   During the first visit of the patients, their name, age, sex, address,  
occupation and income etc. noted. Complaints, probable precipitating factors, prodromal 
illness, contact and family history were also noted.
                    A thorough examination of both general and systemic carried out.  
Dermatological  examination  including  the  number,  site,  size,  morphology  and 
distribution of primary and secondary lesions followed by examination of palms and 
soles,  hair,  nail  and  mucous  membrane  carried  out.  Based  on  this,  patients  were 
classified as classic or atypical variety of Pityriasis rosea.
                    Investigations like haemogram, urine and motion examination, skin 
scraping for fungus, blood VDRL etc. were done.  Skin biopsy was done in 5 cases. 
Mantoux test was done in all cases, to find if there was any immune suppression, as seen 
in the other diseases with viral aetiology, since Pityriasis rosea is also thought to be 
caused by virus. 
                    All the patients were referred to ENT and Dental departments to rule out  
focal sepsis.   All the patients were given symptomatic treatment and followed up for a 
period of 3 months at weekly intervals.  The sequelae and complications if any were 
recorded.  
                   Details thus obtained were compiled, tabulated and statistically summarised.
OBSERVATIONS AND RESULTS
           After analysing 100 cases of Pityriasis Rosea the following observations were 
made.
Sex incidence
Number of Males Number of Females
73 27
             Out of 100 cases studied 27(27%) were females 73 (73%) were males. This 
indicates a male preponderance. (Fig.1) 
Age incidence
            An analysis of 100 cases under study revealed the age incidence as noted in Fig. 
2
Age in yrs Number of cases
0-10 20
11-20 27
21-30 26
31-40 18
41-50 07
51-60 01
61-70 01
                 Maximum incidence was noted in the age group between 11-30 years (53%). 
The youngest patient in the study was 3 years old and the oldest was 68 years old. Age 
and Sex incidence is given in Fig. 3.   
       
FAMILIAL OCCURRENCE
                 There was no history of familial occurrence in the 100 cases studied
PROVOKING FACTORS
1. New clothes – 4 patients (4%) gave history of wearing new clothes, prior to the 
appearance of the rash.
2. Drugs – No patient gave history of drug intake prior to the onset of rash.
3. Stress- Stress in the form of unemployment reported by 2 patients (2%). 
PRODROMAL ILLNESS
            Prodromal illness prior to the onset of rash was reported by 8 patients (8%), of 
whom  1  had  fever  alone,  1  had  fever  with  history  of  jaundice  and  6  had  upper 
respiratory tract infection.
ITCHING
Grade No of patients
Absent 51
Mild 46
Moderate 01
Severe 02
          Itching was graded subjectively. Itching was absent in 51 patients. 49 patients 
(49%) had itching of  whom most  patients  (46)  had only  mild itch.  Among the two 
patients with severe itching, one gave history of swimming in river water, the other had 
lichenoid Pityriasis Rosea.
HERALD PATCH
                 Herald patch was present in 82 cases and absent in 18 cases.
Herald Patch was seen to occur more frequently over the trunk (45) followed by 
Upper limb and Thigh. The size of the herald patch varied from 1 to 7.5 cm in 
diameter. The largest sized herald patch was 7.5cm in diameter. The shape was Oval 
or round with peripheral collerette of scales in all the cases. The central area of the 
patch was light brown coloured and appeared wrinkled in majority of the cases. 
            In 2 patients only Herald patch was seen. One patient had 2 Herald patches. In 
one patient only one secondary lesion was seen near the Herald patch. 
The following are the location of the Herald Patch:
Site of patch Number  of patients
Chest 09
Abdomen 07
Umbilicus 02
Loin 08
Back 16
Shoulder 02
Scapula 01
Neck 04
Face 07
Upper limb 13
Thigh 09
Lower limb (Knee & below knee) 04
 
                           
Secondary lesions
             After a varying period, ranging from 1- 30 days following the appearance of the  
Herald Patch, the generalised eruptions followed. They appeared in crops, intermittently 
at various intervals of 3-10 days. In most of the cases, it appeared on the trunk, upper 
thigh and arms, in a swimming suit distribution. The secondary eruption followed the 
skin cleavage lines/langer’s lines in all the cases.
TYPES OF CLINICAL PRESENTATION
Clinical presentation Number of Patients
Classical 45
Atypical 55
  
                   Both morphology and distribution (typical bathing suit) were Classical in  
45% patients.  In the remaining 55% atypical morphology and/or atypical distribution 
were observed. 
 
Morphology Number of Patients
Classical 71
Atypical 29
Distriution Number of Patients
Classical 79
Atypical 21
ATYPICAL LESIONS
Atypical Morphology:
Papular Pityriasis rosea 19
EMF like Pityriasis rosea 06
Lichenoid Pityriasis rosea 02
Only Herald patch 02
Atypical Distribution:
Inverse Pityriasis rosea 11
Unilateral Pityriasis rosea 01
Flexural 03
Atypical Sites:
Face 07
Palm & soles 03
Distal limb 07
Penis 01
Thighs 02
Abdomen 01
           Morphologically  classical  secondary  lesions  were  seen  in  71  cases. 
Morphologically atypical lesions seen in 27 cases of which papular lesion seen in 19 
cases, erythema multiforme like lesion seen in 6 cases, and Lichenoid  lesion in 2 cases. 
No secondary lesion seen in 2 cases. In one patient only single secondary lesion near the 
Herald patch seen.
              Classical distribution of secondary lesion seen in 79 patients of whom distal 
limb involvement seen in 6 patients, face involvement seen in another 6 patients and 
face and palms & sole involvement in 2 patients. 
             Atypical distribution seen in 18 patients,  of whom 11 cases had inverse 
distribution  of  whom  one  with  few  lesions  over  the  abdomen,  3  had  flexural 
involvement (including 1 with both flexural and distal  limb involvement),  2 patients 
with predominantly involvement of thighs of whom one with lesions over the penis, 1 
case with involvement of abdomen only and 1 case of unilateral Pityriasis Rosea.  2 
patients  had only Herald patch one patient  had a  single  secondary lesion.  Vesicular, 
purpuric, urticarial, and pustular forms were not seen in our patients.
MUCOUS MEMBRANE LESIONS
        In 100 patients analysed no one had lesions over the mucous membrane.
NAIL CHANGES
         No nail changes associated with Pityriasis Rosea observed in all cases.
RECURRENCES
             Only 2 patients gave history of recurrence (past history of similar illness 1 year back) 
in our study.
COMPLICATIONS/ SEQUELAE
                Post inflammatory hypopigmentation was seen in 3 patients (3%). No other 
complication noted in our study. 
TOTAL DURATION OF THE DISEASE
Total duration Number of patients
6 weeks 27
7 weeks 23
8 weeks 31
9 weeks 10
10-14 weeks 09
In 81% of patients the lesions relolved within a period of 6-8 weeks.
ASSOCIATED SKIN DISEASES:
Associated skin disease Number of patients
Acne vulgaris 06
Canites 03
Seborrhoeic Dermatitis 04
Nevus 03
Moluscum contagiosum 01
Lichen nitidus 01
Accessory Nipple 01
Eczema 01
Fibrous polyp 01
P.alba 01
Pediculosis Capitis 01
Polymorphic light eruption 01
Striae distentiae 02
Skin tag 02
Lipoma 01
Tinea versicolor 02
Tinea cruris 01
Traumatic fissure 01
Androgenic alopecia 01
              Active acne vulgaris seen in 5 patients, of whom 1 had eczema also and 1 had 
seborrhoeic dermatitis in addition.  Post Acne scar seen in 1 patient. Nevus achromicus 
seen in 1 patient. Epidermal nevus in 1 patient and combined hypo and hyperpigmented 
moles in 1 patient.
SYSTEMIC INVOLVEMENT
           None of the patients had any systemic abnormality.
BIOPSY
           Skin biopsy done in 27 cases. The findings were consistent with Pityriasis Rosea in all 
cases.
OTHER INVESTIGATIONS
1. Complete Hemogram – 3 patients had elevated ESR. 1had leucopenia.
2. Urine analysis – one patient had jaundice; 1had Hematuria.
3. Motion analysis – No ova or cyst seen in any case.
4. VDRL Test – Negative in all patients. Not done in children and adolescents less than 19 
years of age.
5. Mantoux Test – Positive in 1 child (18mm).
6. Fungal scrapings – Negative in all cases.
Otolaryngologist  opinion 
1. Pharyngitis – 5 patients
2. Tonsillitis – 2 patients
3. Upper respiratory tract infection – 3 patients
4. Allergic rhinitis – 1 patient
5. Deviated nasal septum – 1 patient
6. Ear wax – 1 patient
Dental opinion
1. Chronic gingivitis – 6 patients
2. Chronic periodonditis – 1 patient
3. Dental caries – 7 patients
TREATMENT
         Reassurance was given to all patients by explaining to them the benign self 
limiting non contagious nature of the disease. All are treated symptomatically. Patients 
with mild itching and minimal scaling were treated with emollients and anti histamines 
at  night.  Patients  with  moderate  to  severe  itching  were  given  emollients  and  anti 
histaminic at night along with a course of  tablet erythromycin 250mg 4 times daily for 2 
weeks.
        Recalcitrant cases were treated with topical 0.1% betamethasone cream twice daily  
till symptomatic relief. All the patients were advised to use mild soap, soft loose clothing 
and to avoid irritants on the skin.
Discussion
                In our study maximum incidence was noted in the age group between 11-30 
years (53%). The youngest patient in the study was 3 years old and the oldest was 68 
years old, which is similar to that reported in literature.1, 2 Both sexes are equally 
susceptible according to some authors, while others observed a female preponderance .1, 
9 In our study, a male predominance was observed.       
                 Pityriasis rosea has been labelled as seasonal dermatoses with a higher 
incidence in winter. 1,2,22 In our study, higher incidence has been similarly recorded in the 
winter and rainy seasons, from October to December (55%) and from June to July 
(22%). Case clustering also observed. But sporadic cases were seen throughout the year.
                According to literature wearing of new garments may precipitate or aggravate 
the disease .3 In the present analysis only 4 patients gave a history of wearing new 
garments prior to the onset of the disease. Other provoking factors like and psychogenic 
stress (2%) were also recorded in the present study. Literature reports also indicate 
similar findings. 47 
                 Prodromal illness like upper respiratory tract infection and malaise were seen 
in 8 patients (8%), similar to that seen in literature. 2, 3
                Bjornberg et al  reported that  incidence of  herald patch in Pityriasis rosea was 
50% - 90%. 2,47  The incidence in our patients  was  82% .The location of the Herald 
patch has been seen to occur more frequently on the trunk (42%) followed by upper limb 
and the thigh, which is similar to that reported by Parsons et al and other literatures. 1, 2, 3, 
24
               The herald patch which probably represented the primary 
inoculation site of the virus, according to various authors was seen to occur
over the covered areas of the body. 2, 50 In our study also the Herald patch was
seen to occur over the covered areas of the body in majority (66%) of the
patients. 
                  The Herald patch is absent or undetected in about 20% of cases 1.       
In our study also Herald patch was absent in 18% patients.  Rarely the Herald
patch may be double or multiple often close together 1, 2.  In our study also one
patient had double Herald patches close together.  
               According to literature secondary lesions starts appearing after an interval of 5-
15 days (few hours to 2months), in crops at 2-3 days intervals over 1 week to several 
weeks.1 ,2  In the 100 patients analysed,  after a varying period, ranging from 1- 30 days 
following the appearance of the Herald Patch, the generalised eruptions followed. They 
appeared in crops, intermittently at various intervals of 3-10 days.
               The generalised eruptions have been found to manifest in various 
morphological forms like papular, vesicular, lichenoid, erythema multiforme  – like, 
purpuric, urticarial and pustular forms .64 In our patients  only papular, lichenoid, 
erythema multiforme  – like lesions have been observed. 
             According to Klauder JV Distribution of the secondary eruption over scalp, face 
and penis was uncommon .2, 10   In our study, no scalp involvement was seen, but 1 
patient had penile lesions, 7 patients (7%) had lesions over the face. Involvement of 
palms and soles is also uncommon and was seen in 3 patient (3%) in our study.
             Unilateral Pityriasis Rosea  has been reported in literature. 1  In our study we had 
a case of unilateral Pityriasis Rosea.
               Champion et al observed that mucous membrane involvement is rare in 
Pityriasis rosea, but may involve the oral and genital mucosa. 1, 4 In our study, mucous 
membrane involvement was not seen.
               According to literature, pruritus is mild in 25% of cases, mild to moderate in 
50% cases and severe in 25% cases.51,3  In our study 46% of patients had mild itching, 
1% moderate and 2% had severe itching.
            According to Nelson et al, the majority of the cases had a self limiting course and 
the disease lasted for 6 weeks 2, 56. In the present analysis, 91% of patients had a self 
limiting course of about 6-9 weeks. The longest duration of 14 weeks was observed in 2 
patients one had erythema multiforme  - like Pityriasis rosea, the other one had Classical 
Pityriasis Rosea with palmoplantar involvement.
              In most of the patients (97%) the lesions vanished without trace, which was 
similar to that in literature.2 Post inflammatory hypopigmentation was seen in 3 patients 
(3%). However hyperpigmentation reported in literature was not seen in any of the 100 
cases.2, 3
              Nail dystrophy had been reported   by Silvers and Glickman, 1974, following 
Pityriasis Rosea.2, 80 In our study none of the patients showed any nail changes.
            Literature reports that, Pityriasis rosea is associated with skin diseases like atopy, 
seborheic dermatitis and acne vulgaris.3 In our study also association with seborheic 
dermatitis and acne vulgaris have been found.      
             Bjornberg A et al reported the incidence recurrence of Pityriasis Rosea to be 
2% .There was history of recurrence in 2 cases in our study. 47     
              Mantoux test was negative in 99% of the cases. This also supports the present 
day hypothesis of viral aetiology for Pityriasis rosea, as mantoux test is depressed in 
viral diseases.
SUMMARY AND CONCLUSION
            In this  clinical  analysis,  100 cases of Pityriasis Rosea were analysed in  
Department  of  Dermatology,  Coimbatore  Medical  College  Hospital,  Coimbatore  the 
following points were observed
• Clinical  diagnosis  of  Pityriasis  Rosea was easy,  based on the presence of  Herald 
Patch, characteristic morphology and distribution pattern of the lesions.
• The present study has revealed male preponderance.
• The age incidence was found to be high in adolescents and young adults.
• No familial incidence was observed.
• The diseases were more frequent in the winter and rainy months with sporadic cases 
occurring throughout the year.
• Factors like wearing of new garments, stress and upper respiratory tract infections 
were found to precipitate the disease in some cases.
• The Herald Patch was observed to occur in the covered areas of the body, mostly 
over the trunk. The secondary eruptions had a wide spectrum of morphological forms 
with a variable distribution.  Unilateral  Pityriasis Rosea was also observed in this 
study. 
• Most  of the patients  had complete resolution of  the lesions in 6 to 9 weeks but, 
erythema multiforme  like Pityriasis Rosea and Pityriasis Rosea with palmoplantar 
involvement tends to persist for a longer duration.
• In most  of the patients  the lesions vanished without trace and post  inflammatory 
hypopigmentation was noted in few patients, but none had hyperpigmentation.
• There was no complication in any of the patients. 
• History of recurrence of the disease was also present in 2 cases.
• Histopathological study showed the features of non specific chronic dermatitis.
            In conclusion most of the clinical features, course and complications were 
consistent with the findings reported in the literature.
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PROFORMA
O.P. No:                                                                                     DATE 
Sl.No:
Name
Sex
Age
Address
Occupation
Income
Complaints                                                                            Duration
              1.
              2.
              3.
Present history
Precipitating factors
Prodromal symptoms                                                                         Duration
Past history
Family history
General examination
Dermatological examination
            Herald patch                      No                     Size                Site
                                                                                                   
            Secondary eruptions        Morphology                       Distribution 
            Palms/Soles
            Scalp
            Hair/Nail/Mucous membrane
Associated cutaneous findings
Lymphadenopathy                        Group                                      Distribution
Systemic examination
Investigations
        Blood-            TC
                               DC
                               ESR
        Urine examination
        Motion examination
        Blood VDRL test
        Mantoux test
        Scraping for fungus
        Biopsy
ENT examination
Dental examination
Treatment given
Total duration
Follow up
                         1st    week
                         2nd   week
                         3rd     week
                         4th    week
                         5th    week 
                         6th     week
                         7th    week
                         8th    week 
                         9th     week
                       10th     week
                       11th   week
                       12th   week 
Sequelae
Complications 
Clinical photograph         
Comments
Key to Master chart
•  1˚ to 2˚- Time interval between primary and secondary lesions.
• URI - Upper respiratory tract infection.
• J- Jaundice.
• UL – Upper limb.
• LL – Lower limb.
• DL- Distal limb.
• EMF -  Erythema multiforme .
• And.alo – Androgenic alopecia.
• Seb.dermatitis – Seborheic dermatitis.
• Hypo &hyper pig.mole – Hypo & hyper pigmented mole.
• P.alba – Pityriasis alba.
• Epi.nevus –Epidermal nevus.
• T.cruris – Tinea cruris.
• ESR- Erythrocyte sedimentation rate.
• P.R – Pityriasi rosea.
• Ch.pharyngitis – Chronic pharyngitis.
• D.C – Dental caries.
• Ch.periodonditis – Chronic periodonditis.
• Hypo pigm – Hypo pigmentation.

